New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial

Posted by on May 18, 2020 12:46 pm
Categories: US National Stories

A view of Moderna headquarters in Cambridge, Mass., earlier this month. Moderna is touting preliminary data from a limited coronavirus vaccine trial.

Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.

(Image credit: Maddie Meyer/Getty Images)

Leave a Reply

Your email address will not be published. Required fields are marked *